Sort   by:  
 Page size 
UnknownSafety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial.
Not available
S-EPMC9926325 | biostudies-literature
UnknownReinfection with SARS-CoV-2 in the Omicron Era is Associated with Increased Risk of Post-Acute Sequelae of SARS-CoV-2 Infection: A RECOVER-EHR Cohort Study.
Not available
S-EPMC11974971 | biostudies-literature
UnknownIntegrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
Not available
S-EPMC11416444 | biostudies-literature
UnknownBody Mass Index and Postacute Sequelae of SARS-CoV-2 Infection in Children and Young Adults.
Not available
S-EPMC11581483 | biostudies-literature
UnknownInvestigation of the genetic aetiology of Lewy body diseases with and without dementia.
Not available
S-EPMC11228432 | biostudies-literature
UnknownSecondary surgical-site infection after coronary artery bypass grafting: A multi-institutional prospective cohort study.
Not available
S-EPMC5860945 | biostudies-literature
UnknownTwo-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation.
Not available
S-EPMC4908819 | biostudies-literature
UnknownSurgical ablation of atrial fibrillation during mitral-valve surgery.
Not available
S-EPMC4664179 | biostudies-literature
UnknownBiatrial maze procedure versus pulmonary vein isolation for atrial fibrillation during mitral valve surgery: New analytical approaches and end points.
Not available
S-EPMC6486838 | biostudies-literature
UnknownMitral-valve repair versus replacement for severe ischemic mitral regurgitation.
Not available
S-EPMC4128011 | biostudies-literature
Sort   by:  
 Page size